SS

Sharmil Sanjay Gandhi

Active Director Director DIN 07659873
DIN 07659873 First appointment Nov 2016 Primary industry Information Technology
Unlock full profile Investments · shareholding · contact details
Current companies 5 active board seats
Past companies 2 historical roles
Total affiliations 7 Since Nov 2016
Shareholding value •••• Premium profile

About Sharmil Sanjay Gandhi

Data last updated:

Sharmil Sanjay Gandhi is a Director at Sigma Solve Limited (since 2025), Director at Raybotix Technologies Private Limited (since 2016) and Designated Partner at Kivio Healthcare Llp (since 2026), and holds 2 more current directorships. The companies operate in Information Technology, Energy and Power and Business Services. The 2 current companies with reported revenue have a combined latest revenue of ₹85.10 Cr; the largest is Sigma Solve Limited at ₹77.58 Cr (FY 2025). Earlier, Sharmil Sanjay Gandhi was a Designated Partner at Megatronix Vision Llp (2018–2024) and Designated Partner at Srgandhi Eye Hospitals Llp (2020).

DIN 07659873
Primary Designation Director
Industry Information Technology
First Appointment 24 Nov 2016
Oldest Company Age 16 yrs
Largest company Sigma Solve Limited · ₹77.58 Cr (FY 2025)
Combined revenue ₹85.10 Cr across 2 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Sigma Solve Limited L72200GJ2010PLC060478
Director30 Jun 20252010₹77.58 Cr (FY 2025)Active
Director24 Nov 20162016₹7.52 Cr (FY 2025)Active
Designated Partner17 Jun 20262026Active
Designated Partner11 Oct 20232023Active
Designated Partner14 Aug 20212021Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner13 Mar 20182018Active
Designated Partner24 Jan 20202020Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Raybotix Technologies Private Limited
Srgandhi Hospitals Llp
Sigma Solve Limited
Kalpana Gandhi Family Llp
Premium access

Shareholding and investment profile for Sharmil Sanjay Gandhi

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sharmil Sanjay Gandhi

Sharmil Sanjay Gandhi currently holds 5 directorships: Sigma Solve Limited (Director, since 30 Jun 2025, revenue ₹77.58 Cr (FY 2025)); Raybotix Technologies Private Limited (Director, since 24 Nov 2016, revenue ₹7.52 Cr (FY 2025)); Kivio Healthcare Llp (Designated Partner, since 17 Jun 2026); Kalpana Gandhi Family Llp (Designated Partner, since 11 Oct 2023); Srgandhi Hospitals Llp (Designated Partner, since 14 Aug 2021).

Sharmil Sanjay Gandhi was first appointed on 24 Nov 2016 as Director at Raybotix Technologies Private Limited. The most recent appointment on record is 17 Jun 2026 at Kivio Healthcare Llp.

The 2 current companies of Sharmil Sanjay Gandhi that report revenue have a combined latest revenue of ₹85.10 Cr: Sigma Solve Limited ₹77.58 Cr (FY 2025); Raybotix Technologies Private Limited ₹7.52 Cr (FY 2025).

Sharmil Sanjay Gandhi held 2 earlier board appointments: Megatronix Vision Llp (Designated Partner, 13 Mar 2018 to 01 Aug 2024); Srgandhi Eye Hospitals Llp (Designated Partner, 24 Jan 2020 to 13 Nov 2020).

The current boards of Sharmil Sanjay Gandhi's companies include Aditya Vikrambhai Patel (Sigma Solve Limited), Archana Samirbhai Shah (Sigma Solve Limited), Chinmay Himatlal Shah (Sigma Solve Limited), Dhwani Jaspalsinh Solanki (Sigma Solve Limited), Kalpana Parikh Prakashbhai (Sigma Solve Limited), Prakash Ratilal Parikh (Sigma Solve Limited), among others.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available